Search clinical trials for: 0.0mg placebo Varenicline b.i.d.
Total 239 results
-
PfizerCompleted
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedTobacco DependenceUnited States
-
Oyster Point Pharma, Inc.Completed
-
Sahlgrenska University Hospital, SwedenKarolinska University Hospital; Malmö UniversityCompletedAlcohol DependenceSweden
-
University of South FloridaPfizer; Friedreich's Ataxia Research AllianceTerminatedFriedreich's AtaxiaUnited States
-
Mayo ClinicNational Institutes of Health (NIH)Completed
-
University Hospital, Gentofte, CopenhagenPfizerUnknown
-
PfizerCompletedSmoking CessationUnited States, France, Italy, Spain
-
PfizerWithdrawn
-
Tianjin Chasesun Pharmaceutical Co., LTDSouthwest Hospital, ChinaCompleted
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Mark EisenbergSunnybrook Health Sciences Centre; Unity Health Toronto; Queen Elizabeth II Health...CompletedAcute Coronary SyndromeCanada
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSmoking | Nicotine Dependence | Heavy Drinking
-
Yale UniversityCompleted
-
PfizerCompletedSmoking CessationUnited States, Czech Republic, Korea, Republic of, Brazil, Taiwan, Mexico, France, Italy, Hungary, Germany, Canada, China, Argentina, United Kingdom
-
PfizerCompletedDepression | Smoking CessationSpain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
-
PfizerCompletedHealthy | Non-SmokingUnited States
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Medical University of South CarolinaCompleted
-
PfizerCompletedSmoking CessationUnited States
-
Vance Thompson Vision - MTNot yet recruiting
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Cigarette Smoking
-
Universita degli Studi di CataniaCompletedSmoking Cessation | DiabetesItaly
-
PfizerCompletedSmoking CessationThailand, Singapore, China
-
PfizerCompletedSmoking CessationUnited States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
-
University of StellenboschQuitSupportCompletedTobacco DependenceSouth Africa
-
University of Kansas Medical CenterRecruiting
-
Oyster Point Pharma, Inc.CompletedDry Eye Disease (DED)United States
-
Chugai PharmaceuticalCompletedPrimary OsteoporosisJapan
-
Jiangsu Nhwa Pharmaceutical Co., Ltd.Recruiting
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
University of California, San FranciscoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSubstance DependenceUnited States
-
PfizerCompletedSmoking CessationUnited States, Canada
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)Active, not recruitingNicotine Dependence | VapingUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Stephenson Eye AssociatesRecruiting
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)Completed
-
TakedaCompletedA Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsParkinson's DiseaseJapan
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
Yale UniversityCompletedAlcohol ReactivityUnited States
-
University Health Network, TorontoPfizerUnknown
-
Chongqing Medical UniversityActive, not recruitingDiabetic NephropathyChina
-
PfizerCompletedTobacco Use CessationNorway, Sweden
-
Centre for Addiction and Mental HealthOntario Lung AssociationCompleted
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)Completed
-
PfizerCompletedSmoking CessationColombia, Mexico, Egypt, Jordan, Brazil, Costa Rica, Lebanon, Saudi Arabia, South Africa, United Arab Emirates, Venezuela
-
Mayo ClinicCompletedSmoking | Alcohol Dependence | Tobacco DependenceUnited States
-
University of California, Los AngelesWithdrawnAlcohol Consumption | Cigarette SmokingUnited States